| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 5,015,000 | 5,249,000 | 5,254,000 | 4,913,000 | | Cost of Revenue | 1,413,000 | 1,522,000 | 1,634,000 | 1,583,000 | | | Gross Profit | 3,602,000 | 3,727,000 | 3,620,000 | 3,330,000 | | | Operating Expenses | | Research Development | 923,000 | 1,143,000 | 834,000 | 813,000 | | Selling General and Administrative | 1,388,000 | 1,734,000 | 1,570,000 | 1,485,000 | | Non Recurring | 131,000 | (902,000) | 56,000 | 64,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,160,000 | 1,752,000 | 1,160,000 | 968,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 78,000 | 70,000 | 68,000 | (53,000) | | Earnings Before Interest And Taxes | 1,384,000 | 1,961,000 | 1,392,000 | 1,065,000 | | Interest Expense |
-
| 73,000 | 237,000 | (73,000) | | Income Before Tax | 1,384,000 | 1,888,000 | 1,155,000 | 1,138,000 | | Income Tax Expense | 463,000 | 424,000 | 308,000 | 229,000 | | Minority Interest |
-
| (266,000) | (259,000) | (241,000) | | | | Net Income From Continuing Ops | 921,000 | 1,198,000 | 588,000 | 668,000 | | | Non-recurring Events | | Discontinued Operations |
-
| 46,000 | 1,990,000 | 96,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 921,000 | 1,244,000 | 2,578,000 | 764,000 | | Preferred Stock And Other Adjustments | (283,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $638,000 | $1,244,000 | $2,578,000 | $764,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
